Fund Holdings — First Turn Management, LLC

Total Portfolio Value:
$752.98M
Total Bought:
$223.24M
Total Sold:
$379.69M
Net Transaction:
-$156.45M
Notable People:
Lisa Gable Wheatley, Tracy Austin Murphy, Stephen Allyn Rosetta
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Enliven Therapeutics Inc954,360958,700+4,340$48.43M$43.95M5.84%-$4.49M
Guardant Health, Inc.(GH)0219,304+219,304$0$39.12M5.19%+$39.12M
ABIVAX Société AnonymeADS(ABVX)489,889384,592-105,297$65.28M$38.08M5.06%-$27.20M
Roivant Sciences Ltd.SHS(ROIV)1,331,066985,583-345,483$47.11M$36.04M4.79%-$11.06M
United Therapeutics Corporation(UTHR)84,93260,064-24,868$46.02M$32.55M4.32%-$13.47M
Viridian Therapeutics, Inc.(VRDN)1,670,0001,525,220-144,780$30.68M$31.40M4.17%+$726.4K
Axsome Therapeutics, Inc.(AXSM)218,415162,407-56,008$53.46M$29.95M3.98%-$23.52M
Insmed Incorporated(INSM)263,851245,726-18,125$28.13M$28.05M3.72%-$84.6K
Celcuity Inc.(CELC)329,101329,1010$34.43M$26.17M3.48%-$8.26M
Charles River Laboratories International, Inc.(CRL)086,801+86,801$0$25.61M3.40%+$25.61M
Cytokinetics, Incorporated(CYTK)527,412357,945-169,467$44.93M$23.59M3.13%-$21.34M
BridgeBio Pharma, Inc.(BBIO)633,364354,371-278,993$47.17M$23.32M3.10%-$23.86M
Praxis Precision Medicines, Inc.(PRAX)83,52878,806-4,722$27.96M$22.95M3.05%-$5.01M
Oric Pharmaceuticals Inc2,017,2841,574,334-442,950$21.85M$21.21M2.82%-$640.9K
Repligen Corporation(RGEN)0108,436+108,436$0$20.84M2.77%+$20.84M
Tango Therapeutics, Inc.(TNGX)0766,860+766,860$0$19.13M2.54%+$19.13M
Revolution Medicines, Inc.(RVMD)415,30792,316-322,991$77.78M$18.95M2.52%-$58.83M
Inhibrx Biosciences, Inc.(INBX)164,783171,512+6,729$15.61M$17.16M2.28%+$1.55M
Newamsterdam Pharma Company
ORDINARY SHARES
582,497702,396+119,899$19.74M$17.08M2.27%-$2.66M
Veradermics, Incorporated(MANE)0136,718+136,718$0$16.57M2.20%+$16.57M
Cogent Biosciences, Inc.(COGT)602,281514,976-87,305$23.31M$16.49M2.19%-$6.82M
Dianthus Therapeutics, Inc.(DNTH)285,771178,573-107,198$27.86M$15.72M2.09%-$12.13M
Palvella Therapeutics, Inc.(PVLA)156,450109,871-46,579$23.91M$15.15M2.01%-$8.75M
Rhythm Pharmaceuticals, Inc.(RYTM)154,018157,603+3,585$17.10M$15.01M1.99%-$2.09M
Arcus Biosciences, Inc.(RCUS)0577,693+577,693$0$14.92M1.98%+$14.92M
Arrowhead Pharmaceuticals, Inc.(ARWR)0222,649+222,649$0$14.57M1.94%+$14.57M
Disc Medicine, Inc.(IRON)0220,666+220,666$0$14.44M1.92%+$14.44M
Erasca, Inc.(ERAS)1,221,721913,452-308,269$22.38M$13.39M1.78%-$8.99M
GRAIL, Inc.(GRAL)093,727+93,727$0$13.13M1.74%+$13.13M
Kymera Therapeutics, Inc.(KYMR)102,533113,299+10,766$11.76M$12.67M1.68%+$908.2K
Ascendis Pharma A/S(ASND)104,87754,594-50,283$27.97M$12.44M1.65%-$15.53M
uniQure N.V.SHS(QURE)608,925465,474-143,451$28.05M$11.25M1.49%-$16.80M
Xenon Pharmaceuticals Inc.(XENE)600,200297,060-303,140$36.23M$11.05M1.47%-$25.18M
Spyre Therapeutics, Inc.(SYRE)0102,541+102,541$0$9.13M1.21%+$9.13M
Summit Therapeutics Inc.(SMMT)0501,724+501,724$0$8.48M1.13%+$8.48M
Definium Therapeutics, Inc.(DFTX)0216,531+216,531$0$8.24M1.09%+$8.24M
Vaxcyte, Inc.(PCVX)443,836137,534-306,302$25.80M$7.83M1.04%-$17.97M
Hinge Health, Inc.CL A(HNGE)075,448+75,448$0$7.34M0.97%+$7.34M
Apogee Therapeutics Inc138,8220-138,822$18.43M$0—-$18.43M
Mirum Pharmaceuticals, Inc.(MIRM)218,0510-218,051$25.53M$0—-$25.53M
Nuvalent Inc26,2980-26,298$3.25M$0—-$3.25M
Oruka Therapeutics, Inc.(ORKA)155,3430-155,343$14.78M$0—-$14.78M
Scholar Rock Holding Corporation(SRRK)271,2270-271,227$14.92M$0—-$14.92M
Sionna Therapeutics, Inc.(SION)110,4930-110,493$4.86M$0—-$4.86M
Page 1 of 1
First Turn Management, LLC — 13F Holdings — Q3 2026 | TickerTrail